- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
Highlighting the Acne Bootcamp from AAD 2022
Author(s):
Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.
In this intervew on a presentation given at the American Academy of Dermatology, Christopher Bunick, MD, PhD, of Yale University, discusses various treatments acne vulgaris, including one option that is associated with one of the more commonly reported adverse events associated with these therapies - gastrointestinal illness.
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research
Apoptosis-Based Skin Cancer Treatment Shows Promise
Mastering Dermoscopy and Dysplastic Nevi
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
How to Avoid Complications With Radiofrequency and Ultrasound-Based Technologies
Michael Gold, MD: Insights on Silicone, Energy-Based Devices, and Radiation Therapy
Related Content
